ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,150Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 223

$573K Total Retail Price of All Prescriptions

Rank: 47 out of 223

444 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 444 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 444 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 7,913 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
LEVOTHYROXINE SODIUM 547 488 1 2
SIMVASTATIN 358 327 2 1
OMEPRAZOLE 353 314 3 3
HYDROCODONE-ACETAMINOPHEN 262 230 S3 4 5
PRAVASTATIN SODIUM 262 242 4 15
AMLODIPINE BESYLATE 194 186 6 6
BENAZEPRIL HCL 161 148 7 57
ALENDRONATE SODIUM 158 156 8 19
CITALOPRAM HBR 153 126 9 16
ATORVASTATIN CALCIUM 147 133 10 17
GABAPENTIN 132 95 11 10
ZOLPIDEM TARTRATE 131 96 12 8
BENAZEPRIL-HYDROCHLOROTHIAZIDE 121 112 13 135
LISINOPRIL 118 100 14 4
FLUTICASONE PROPIONATE 117 95 15 27
CARVEDILOL 110 110 16 23
TRAMADOL HCL 110 108 16 18
TRIAMTERENE-HCTZ 104 95 18 39
DICLOFENAC SODIUM 101 87 19 76
FUROSEMIDE 101 98 19 9
METFORMIN HCL 101 88 19 7
METOPROLOL SUCCINATE 99 79 22 20
CRESTOR 99 92 22 37
WARFARIN SODIUM 89 86 24 11
FENOFIBRATE 88 71 25 38
LOSARTAN-HYDROCHLOROTHIAZIDE 86 84 26 31
PANTOPRAZOLE SODIUM 81 69 27 45
SYNTHROID 74 70 28 35
POTASSIUM CHLORIDE 73 59 29 12
SERTRALINE HCL 71 58 30 21
TAMSULOSIN HCL 70 70 31 26
LANTUS 69 57 32 34
NAMENDA 68 68 33 48
LEVOXYL 66 60 34 78
CEPHALEXIN 65 55 35 139
ROPINIROLE HCL 62 57 36 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 54 36 113
GLIMEPIRIDE 62 62 36 30
PAROXETINE HCL 60 57 39 52
VERAPAMIL ER 58 58 40 89
TRAZODONE HCL 58 41 40 22
DONEPEZIL HCL 58 58 40 36
ALLOPURINOL 56 48 43 28
ADVAIR DISKUS 55 52 44 47
CIPROFLOXACIN HCL 53 50 45 53
CARISOPRODOL 53 36 R 45 63
LOSARTAN POTASSIUM 52 52 47 14
MELOXICAM 51 50 48 33
FLUOXETINE HCL 50 48 49 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 4, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.